Clinical trial Recruiting at 1 site Observational Ages 20 to 60

How thyroid problems affect liver blood tests

Official title: Impact Of Thyroid Dysfunction on Liver Function Tests In Sohag University Hospital

Run by Sohag University · NCT07354048 · Data updated 2026-11-12

This observational study will see if adults aged 20–60 with treated, untreated, or newly diagnosed hypo- or hyperthyroidism have different liver blood test results compared with healthy euthyroid controls.

Quick facts

Study typeObservational
Ages20 Years to 60 Years
SexAll
Enrollment100 (estimated)
SponsorSohag University
Academic / other
Locations1 site (Sohag)
StatusRecruiting
StartedJuly 14, 2025
Main results expectedJanuary 30, 2026
Study endsJanuary 30, 2026
Registry record updatedJanuary 21, 2026
Trial IDNCT07354048 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 20–60 with hypothyroidism or hyperthyroidism (including treated/controlled, treated/uncontrolled, and newly diagnosed cases) or healthy euthyroid adults without liver disease, pregnancy, severe infection, heart disease, or use of medications that affect liver function.

Probably not a fit

Children under 20, adults outside the 20–60 age range, people with known liver disease, pregnant or lactating women, those with severe infections or heart disease, or anyone taking drugs that affect liver function are unlikely to be eligible or to benefit from the study's findings.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This single-center observational study at Sohag University Hospital will compare liver function tests among adults aged 20–60 who have hypothyroidism or hyperthyroidism (treated and controlled, treated but uncontrolled, or newly diagnosed) and healthy euthyroid controls. Participants will undergo clinical assessment and blood sampling to measure standard liver function parameters, with exclusions for known liver disease, pregnancy or lactation, severe infection, heart disease, or medications that affect liver function. No experimental treatments are given; the study analyzes disease status and laboratory results to identify patterns and associations. The goal is to clarify how different thyroid states correlate with common liver test abnormalities.

Why it matters

Potential benefit: If successful, results could help doctors interpret abnormal liver tests in people with thyroid dysfunction and reduce unnecessary liver workups.

How similar studies have gone: Previous observational studies have reported associations between thyroid dysfunction and abnormal liver function tests, so this study builds on an established but still-evolving evidence base.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* All patients between the ages of 20-60 years old either with Hypothyroidism or Hyperthyroidism (controlled on treatment or not) and firstly diagnosed Hypothyroidism or Hyperthyroidism.
* Euthyroid controls (clinically healthy control subjects were recruited from the general population with the same socio-economic status with the subjects.)

Exclusion Criteria:

* Patients aged \< 20 years old.
* Patients With Liver Disease.
* Pregnant and lactating women.
* Patients with severe infections or sepsis.
* Patients with Heart Disease.
* Patients who on drugs that can affect liver function such as phenothiazine, phenylbutazone, methyldopa, among others.

Where it's running

  • Sohag University Hospital
    Sohag, Egypt
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.